Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.

Saved in:
Bibliographic Details
Title: Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
Authors: Schefold JC (AUTHOR), Zeden J (AUTHOR), Pschowski R (AUTHOR), Hammoud B (AUTHOR), Fotopoulou C (AUTHOR), Hasper D (AUTHOR), Fusch G (AUTHOR), Von Haehling S (AUTHOR), Volk H (AUTHOR), Meisel C (AUTHOR), Schütt C (AUTHOR), Reinke P (AUTHOR)
Source: Scandinavian Journal of Infectious Diseases. 2010, Vol. 42 Issue 3, p164-171. 8p.
URL: 47927829
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00365548
DOI:10.3109/00365540903405768